We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+11.05%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.53B
AUM Growth
-$150M
Cap. Flow
-$510M
Cap. Flow %
-11.27%
Top 10 Hldgs %
8.72%
Holding
765
New
71
Increased
198
Reduced
404
Closed
78

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.4M
2
EW icon
Edwards Lifesciences
EW
+$11.1M
3
RNST icon
Renasant Corp
RNST
+$10.9M
4
AAPL icon
Apple
AAPL
+$9.67M
5
NCNO icon
nCino
NCNO
+$9.65M

Top Sells

Rank Stock Value
1
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$20.2M
2
TBBK icon
The Bancorp
TBBK
+$15.8M
3
AIZ icon
Assurant
AIZ
+$12.5M
4
NDSN icon
Nordson
NDSN
+$12.5M
5
VAC icon
Marriott Vacations Worldwide
VAC
+$12.4M

Sector Composition

Rank Sector Weight
1 Financials 20.06%
2 Industrials 18.84%
3 Healthcare 17.71%
4 Technology 13.16%
5 Consumer Discretionary 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDIT icon
526
Editas Medicine
EDIT
$432M
$1.84M 0.04%
540,135
+407,487
+307% +$1.77M
AVD icon
527
American Vanguard Corp
AVD
$65.5M
$1.83M 0.04%
346,069
+266,358
+334% +$1.89M
PKE icon
528
Park Aerospace
PKE
$801M
$1.81M 0.04%
139,138
+4,515
+3% +$59.9K
OVID icon
529
Ovid Therapeutics
OVID
$489M
$1.8M 0.04%
1,527,985
+39,414
+3% +$41.2K
ZYME icon
530
Zymeworks
ZYME
$1.71B
$1.8M 0.04%
143,580
-1,942
-1% -$21.1K
MX icon
531
Magnachip Semiconductor
MX
$134M
$1.76M 0.04%
376,898
+24,257
+7% +$118K
ARRY icon
532
Array Technologies
ARRY
$819M
$1.76M 0.04%
266,277
-421,064
-61% -$3.46M
FNB icon
533
FNB Corp
FNB
$6.75B
$1.75M 0.04%
123,858
-288,998
-70% -$4.13M
AXSM icon
534
Axsome Therapeutics
AXSM
$11.4B
$1.75M 0.04%
19,431
-1,184
-6% -$103K
XERS icon
535
Xeris Biopharma Holdings
XERS
$1.46B
$1.72M 0.04%
+604,857
New +$1.55M
DINO icon
536
HF Sinclair
DINO
$15.2B
$1.72M 0.04%
38,588
-1,665
-4% -$79.5K
BMI icon
537
Badger Meter
BMI
$3.95B
$1.72M 0.04%
7,863
-1,136
-13% -$228K
NE icon
538
Noble Corp
NE
$6.95B
$1.69M 0.04%
46,870
-1,970
-4% -$79.4K
FFIV icon
539
F5
FFIV
$23.2B
$1.68M 0.04%
7,607
-1,012
-12% -$196K
SYK icon
540
Stryker
SYK
$133B
$1.63M 0.04%
4,502
+192
+4% +$66.3K
TSEM icon
541
Tower Semiconductor
TSEM
$28.5B
$1.62M 0.04%
36,654
-3,687
-9% -$151K
ABUS icon
542
Arbutus Biopharma
ABUS
$907M
$1.62M 0.04%
419,905
-37,673
-8% -$145K
CBT icon
543
Cabot Corp
CBT
$4.46B
$1.61M 0.04%
14,396
-31,617
-69% -$3.15M
ITOS
544
DELISTED
iTeos Therapeutics
ITOS
$1.59M 0.04%
155,435
+5,185
+3% +$79.1K
CTBI icon
545
Community Trust Bancorp
CTBI
$1.41B
$1.54M 0.03%
31,062
-225
-0.7% -$10.8K
WS icon
546
Worthington Steel
WS
$1.94B
$1.54M 0.03%
45,309
-1,956
-4% -$67.2K
RIGL icon
547
Rigel Pharmaceuticals
RIGL
$778M
$1.53M 0.03%
94,549
+4,615
+5% +$54.3K
PBYI icon
548
Puma Biotechnology
PBYI
$449M
$1.51M 0.03%
+593,046
New +$1.8M
CADE
549
DELISTED
Cadence Bank
CADE
$1.49M 0.03%
46,928
-142,704
-75% -$4.42M
HURC icon
550
Hurco Companies Inc
HURC
$141M
$1.49M 0.03%
70,779
-958
-1% -$16.4K
20 21
22
23 24

Similar funds

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $4.76B AUM 10.22% 1-Year Est. Return

Kennedy Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Kennedy Capital Management held 765 positions worth $4.53B, down 3.2% from $4.68B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Kennedy Capital Management withdrew a net $510M in Q3 2024, closing 78 positions and reducing 404 holdings. Its most notable exit was Silk Road Medical, Inc. Common Stock, an estimated $20.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Kennedy Capital Management opened a new position in Edwards Lifesciences worth $10.1M.

  • Kennedy Capital Management's largest Q3 2024 buy was Edwards Lifesciences: 153,046 shares worth $10.1M.
  • Kennedy Capital Management added most to Microsoft in Q3 2024, an estimated $11.4M increase.
  • Kennedy Capital Management's biggest Q3 2024 reduction was The Bancorp, cutting an estimated $15.8M.
  • Kennedy Capital Management fully exited Silk Road Medical, Inc. Common Stock in Q3 2024, selling an estimated $20.2M.
  • Kennedy Capital Management's ten largest holdings make up 8.7% of its $4.53B portfolio in Q3 2024.
  • Kennedy Capital Management opened 71 new positions and closed 78 in Q3 2024.
  • Kennedy Capital Management's portfolio value fell 3.2% quarter-over-quarter to $4.53B.

Based on Kennedy Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.